The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lioresal 5mg/5ml Oral solution



Novartis Ireland LimitedPA0896/017/002

Main Information

Trade NameLioresal 5mg/5ml Oral solution
Active SubstancesBaclofen
Dosage FormOral solution
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/017/002

Group Information

ATC CodeM03BX Other centrally acting agents
M03BX01 baclofen

Status

License statusAuthorised
Licence Issued18/04/1984
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back